470495-2020 - Competition

NHS Framework for the Midlands and East, Branded Medicines — Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.

CM/PHR/20/5591/01 — Midlands and East, Branded Medicines — Tranche B. Period of framework: 1 March 2021 to 28 February 2023 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

CM/PHR/20/5591/02 — Midlands and East Branded Medicines — Annual Tranche, cytokine modulators, other monoclonal antibodies Interleukin Inhibitors, JAK Inhibitors and medicines for migraine and asthma. Period of framework: 1 March 2021 to 28 February 2022 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.

CM/PHR/20/5591/03 — Supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to Pan London. Period of framework: 1 March 2021 to 31 August 2021.

CM/PHR/20/5591/04 — Supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to South of England. Period of framework: 1 March 2021 to 31 August 2021.

Lot 4: (SOFE) — Interleukin Inhibitors, JAK Inhibitors, Migraine and Asthma

Main site or place of performance: Please refer to document No 10 for a full list of participating authorities.

CM/PHR/20/5591/04 — NHS Framework agreement for the supply of interleukin inhibitors, JAK inhibitors and medicines for migraine and asthma to South of England. Period of framework: 1 March 2021 to 31 August 2021.

Lot 3: (LNW) — Interleukin Inhibitors, JAK Inhibitors, Migraine and Asthma

Main site or place of performance: Please refer to document No 10 for a full list of participating authorities.

CM/PHR/20/5591/03 — NHS Framework agreement for the supply of interleukin inhibitors, JAK inhibitors and medicines for migraine and asthma to Pan London. Period of framework: 1 March 2021 to 31 August 2021.

Lot 2: Midlands and East Cytokine Modulators and Other Monoclonal Antibodies

Main site or place of performance: Please refer to document No 10 for a full list of participating authorities.

CM/PHR/20/5591/02 — NHS Framework for the Midlands and East Branded Medicines — annual tranche, cytokine modulators, other monoclonal antibodies interleukin inhibitors, JAK inhibitors and medicines for migraine and asthma. Period of framework: 1 March 2021 to 28 February 2022 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.

Description of options:

Lot 1: Midlands and East (MAE) Tranche B

Main site or place of performance: Please refer to document No 10 for a full list of participating authorities.

CM/PHR/20/5591/01 — NHS Framework for the Midlands and East, Branded Medicines — Tranche B. Period of framework: 1 March 2021 to 28 February 2023 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

Description of options:

Place:

Information about authorised persons and opening procedure: Commercial Medicines Unit employee.

Electronic ordering will be used

Electronic invoicing will be accepted

Electronic payment will be used

Responding to this notice

Any supplier may be disqualified who does not respond to the following in the requisite manner.

1) Submission of expression of interest and procurement specific information

This procurement exercise will be conducted on the eTendering portal at https://health-family.force.com/s/Welcome Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested) through the eTendering portal as follows:

1.1) if not already registered, candidates should register on the eTendering portal at https://health-family.force.com/s/Welcome and click the link to register:

— agree to the user agreement,

— populate company details;

1.2) once registered, candidates must register interest as follows:

— log to the portal,

— select ‘Find Opportunities’ from the supplier home screen, use the ‘Sort by’: facility to find this opportunity and select the bold blue title to select,

— review opportunity details and click ‘Register Interest’,

— as you select the opportunity, you can review documents, send clarification messages, submit the response or decline to respond (if you decide not to participate in the opportunity);

1.3) there is a supplier user guide on using the system and candidates can contact the Atamis helpdesk at support-health@atamis.co.uk or by calling 08009956035 for technical assistance when completing responses.

2) General supplier information.

To manage and assess supplier information the contracting authority requests candidates provide their company profile in the Government's Supplier Registration Service (which has replaced sid4gov), as follows.

2.1) If not already registered (the previous sid4gov password, login and details will still be on the system), candidates must go to the following web page https://supplierregistration.cabinetoffice.gov.uk and select ‘Register’ at the top of the page. Key in details as requested to search for your company. If you do not have a D-U-N-S® Number, click on the link at the right of the page to obtain a number from D&B. Candidates must obtain a Dun and Bradstreet (D&B) D-U-N-S® Number to enable registration on the system.

2.2) Once registration is complete you are able to create and update your company profile. Candidates should ensure all the mandatory fields of their profile are completed and up to date for each procurement exercise. D&B data will be supplied automatically by D&B.

2.3) For further help or information concerning this telephone +44(0) 1614137982 or via the message function on the website.

Other contracting authorities

The framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.